Vontobel Holding Ltd. Immunity Bio, Inc. Transaction History
Vontobel Holding Ltd.
- $28.9 Billion
- Q2 2025
A detailed history of Vontobel Holding Ltd. transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Vontobel Holding Ltd. holds 10,000 shares of IBRX stock, worth $30,099. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,000
Previous 16,000
37.5%
Holding current value
$30,099
Previous $48,000
45.83%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding IBRX
# of Institutions
246Shares Held
80.5MCall Options Held
1.09MPut Options Held
2.73M-
Vanguard Group Inc Valley Forge, PA20.3MShares$61.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$34.4 Million0.0% of portfolio
-
State Street Corp Boston, MA7.58MShares$22.8 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA4.29MShares$12.9 Million0.0% of portfolio
-
Woodline Partners LP San Francisco, CA3.45MShares$10.4 Million0.07% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $1.2B
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...